Tiziana Life Sciences Ltd(NASDAQ:TLSA)创立于1998年,总部位于英国伦敦,全职雇员9人,是一家生物科技公司,致力于发现和开发新型分子和相关疗法,以治疗肿瘤学和免疫学领域未满足的医疗需求。 Tiziana Life Sciences Ltd(TLSA)美股百科 Tiziana Life Sciences 是一家在纳斯达克上市(纳斯达克股票代码:TLSA)的临床阶段生物...
Valtis, MD, second-year fellow in medical oncology at Memorial Sloan Kettering Cancer Center, discussed this research on the real-world incidence, prevention, and management of TLS in patients with CLL who were treated with venetoclax in the inpatient and outpatient settings. Yannis K. Valtis,...